DURVALUMAB, PACLITAXEL ALBUMIN-BOUND, Ceralasertib
IFOM-CPT008/2022/PO0
Phase 2 small_molecule active
Quick answer
DURVALUMAB, PACLITAXEL ALBUMIN-BOUND, Ceralasertib for ADVANCED TRIPLE NEGATIVE BREAST CANCER is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- ADVANCED TRIPLE NEGATIVE BREAST CANCER
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active